Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45


Selection Criteria for Determination of Optimal Reconstruction Method for Cu-64 Trastuzumab Dosimetry on Siemens Inveon PET Scanner.

Lee S, Kim H, Kang YR, Kim H, Kim JY, Lee YJ, Kim JM, Kim JS.

J Clin Med. 2019 Apr 14;8(4). pii: E512. doi: 10.3390/jcm8040512.


Synthesis and Feasibility Evaluation of a new Trastuzumab Conjugate Integrated with Paclitaxel and 89Zr for Theranostic Application Against HER2-Expressing Breast Cancers.

Jang JH, Han SJ, Kim JY, Kim KI, Lee KC, Kang CS.

ChemistryOpen. 2019 Apr 8;8(4):451-456. doi: 10.1002/open.201900037. eCollection 2019 Apr.


Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis.

Jung KH, Lee YJ, Kim JY, Lee KC, Park JA, Choi JY.

J Vis Exp. 2019 Jan 7;(143). doi: 10.3791/58218.


Image-Guided Neutron Capture Therapy Using the Gd-DO3A-BTA Complex as a New Combinatorial Treatment Approach.

Jung KH, Park JA, Kim JY, Kim MH, Oh S, Kim HK, Choi EJ, Kim HJ, Do SH, Lee KC, Kim KM, Lee YJ, Chang Y.

Contrast Media Mol Imaging. 2018 Nov 1;2018:3727109. doi: 10.1155/2018/3727109. eCollection 2018.


Evidence-based Treatment for Low-grade Glioma.

Semmel D, Ware C, Kim JY, Peters KB.

Semin Oncol Nurs. 2018 Dec;34(5):465-471. doi: 10.1016/j.soncn.2018.10.008. Epub 2018 Nov 2. Review.


PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models.

Lee TS, Song IH, Shin JI, Park YS, Kim JY, Kim KI, Lee YJ, Kang JH.

Cells. 2018 Oct 27;7(11). pii: E187. doi: 10.3390/cells7110187.


Head-to-head comparison of 18 F-FP-CIT and 123 I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: A preliminary study.

Lee I, Kim JS, Park JY, Byun BH, Park SY, Choi JH, Moon H, Kim JY, Lee KC, Chi DY, Kim KM, Lim I, Kang JH, Ahn SH, Kim BI, Ha JH, Lim SM.

Synapse. 2018 Jul;72(7):e22032. doi: 10.1002/syn.22032. Epub 2018 Mar 9.


Radiometallic Complexes of DO3A-Benzothiazole Aniline for Nuclear Medicine Theranostics.

Park JA, Lee JW, Kim HK, Shin UC, Lee KC, Kim TJ, Chang Y, Kim KM, Kim JY, Lee YJ.

Mol Pharm. 2018 Mar 5;15(3):1133-1141. doi: 10.1021/acs.molpharmaceut.7b00996. Epub 2018 Feb 13.


High in Vivo Stability of 64Cu-Labeled Cross-Bridged Chelators Is a Crucial Factor in Improved Tumor Imaging of RGD Peptide Conjugates.

Sarkar S, Bhatt N, Ha YS, Huynh PT, Soni N, Lee W, Lee YJ, Kim JY, Pandya DN, An GI, Lee KC, Chang Y, Yoo J.

J Med Chem. 2018 Jan 11;61(1):385-395. doi: 10.1021/acs.jmedchem.7b01671. Epub 2018 Jan 3.


Development of a disposable kit with fully automatic self-shielding reactor for [18F]FDG synthesis.

Oh S, Nam K, Lee KC, Ghergherehchi M, Kim B, Kim JY, Song HS, Chai JS.

Appl Radiat Isot. 2018 Jan;131:23-29. doi: 10.1016/j.apradiso.2017.10.044. Epub 2017 Oct 26.


Preliminary 19F-MRS Study of Tumor Cell Proliferation with 3'-deoxy-3'-fluorothymidine and Its Metabolite (FLT-MP).

Ko IO, Jung KH, Kim MH, Kang KJ, Lee KC, Kim KM, Noh I, Lee YJ, Lim SM, Kim JY, Park JA.

Contrast Media Mol Imaging. 2017 Sep 26;2017:3981358. doi: 10.1155/2017/3981358. eCollection 2017.


Radiolabeling and preliminary biodistribution study of 99mTc-labeled antibody-mimetic scaffold protein repebody for initial clearance properties.

Mushtaq S, Rho JK, Kang JA, Lee JJ, Kim JY, Nam YR, Yun SJ, Lee GH, Park SH, Lee DE, Kim HS.

Bioorg Med Chem Lett. 2017 Nov 15;27(22):5060-5064. doi: 10.1016/j.bmcl.2017.09.047. Epub 2017 Sep 25.


64Cu-Labeled Repebody Molecules for Imaging of Epidermal Growth Factor Receptor-Expressing Tumors.

Pyo A, Yun M, Kim HS, Kim TY, Lee JJ, Kim JY, Lee S, Kwon SY, Bom HS, Kim HS, Kim DY, Min JJ.

J Nucl Med. 2018 Feb;59(2):340-346. doi: 10.2967/jnumed.117.197020. Epub 2017 Sep 15.


A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors.

Yun M, Kim DY, Lee JJ, Kim HS, Kim HS, Pyo A, Ryu Y, Kim TY, Zheng JH, Yoo SW, Hyun H, Oh G, Jeong J, Moon M, Min JH, Kwon SY, Kim JY, Chung E, Hong Y, Lee W, Kim HS, Min JJ.

Theranostics. 2017 Jun 25;7(10):2620-2633. doi: 10.7150/thno.18096. eCollection 2017.


Improved Pharmacokinetics Following PEGylation and Dimerization of a c(RGD-ACH-K) Conjugate Used for Tumor Positron Emission Tomography Imaging.

Lee JW, Lee YJ, Shin UC, Kim SW, Kim BI, Lee KC, Kim JY, Park JA.

Cancer Biother Radiopharm. 2016 Oct;31(8):295-301.


New Glucocyclic RGD Dimers for Positron Emission Tomography Imaging of Tumor Integrin Receptors.

Lee JW, Park JA, Lee YJ, Shin UC, Kim SW, Kim BI, Lim SM, An GI, Kim JY, Lee KC.

Cancer Biother Radiopharm. 2016 Aug;31(6):209-16. doi: 10.1089/cbr.2016.2015. Epub 2016 Jul 12.


Immobilization of the Gas Signaling Molecule H2 S by Radioisotopes: Detection, Quantification, and In Vivo Imaging.

Sarkar S, Ha YS, Soni N, An GI, Lee W, Kim MH, Huynh PT, Ahn H, Bhatt N, Lee YJ, Kim JY, Park KM, Ishii I, Kang SG, Yoo J.

Angew Chem Int Ed Engl. 2016 Aug 1;55(32):9365-70. doi: 10.1002/anie.201603813. Epub 2016 Jul 8.


Evaluation of [(89)Zr]-Oxalate as a PET Tracer in Inflammation, Tumor, and Rheumatoid Arthritis Models.

Park JA, Lee YJ, Lee JW, Yoo RJ, Shin UC, Lee KC, Kim BI, Kim KM, Kim JY.

Mol Pharm. 2016 Jul 5;13(7):2571-7. doi: 10.1021/acs.molpharmaceut.6b00411. Epub 2016 Jun 20.


Phosphonate Pendant Armed Propylene Cross-Bridged Cyclam: Synthesis and Evaluation as a Chelator for Cu-64.

Bhatt N, Soni N, Ha YS, Lee W, Pandya DN, Sarkar S, Kim JY, Lee H, Kim SH, An GI, Yoo J.

ACS Med Chem Lett. 2015 Oct 20;6(11):1162-6. doi: 10.1021/acsmedchemlett.5b00362. eCollection 2015 Nov 12.


Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.

Dale AV, An GI, Pandya DN, Ha YS, Bhatt N, Soni N, Lee H, Ahn H, Sarkar S, Lee W, Huynh PT, Kim JY, Gwon MR, Kim SH, Park JG, Yoon YR, Yoo J.

Inorg Chem. 2015 Sep 8;54(17):8177-86. doi: 10.1021/acs.inorgchem.5b01386. Epub 2015 Aug 19.


Supplemental Content

Loading ...
Support Center